NPI: 1558607481 · PULASKI, VA 24301 · Community/Behavioral Health Agency · NPI assigned 12/21/2012
Authorized official TANIS, ROBYN controls 20+ related entities in our dataset. Read more
| Authorized Official | TANIS, ROBYN (EXECUTIVE DIRECTOR OF CONTRACT MGMT) |
| NPI Enumeration Date | 12/21/2012 |
Other providers sharing the same authorized official: TANIS, ROBYN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 164,315 | $1.89M |
| 2019 | 399,370 | $3.24M |
| 2020 | 368,384 | $4.78M |
| 2021 | 406,289 | $5.60M |
| 2022 | 469,850 | $4.83M |
| 2023 | 394,218 | $4.33M |
| 2024 | 344,349 | $3.75M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 999,347 | 46,534 | $9.17M |
| G9012 | Other specified case management service not elsewhere classified | 37,970 | 34,532 | $8.33M |
| S0109 | Methadone, oral, 5 mg | 1,097,149 | 36,095 | $4.92M |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 170,524 | 6,658 | $2.27M |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 38,380 | 27,505 | $1.31M |
| 80305 | 111,349 | 42,229 | $1.17M | |
| J0575 | Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine | 62,969 | 2,733 | $613K |
| H0014 | Alcohol and/or drug services; ambulatory detoxification | 3,084 | 2,242 | $265K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,575 | 3,326 | $161K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,410 | 1,249 | $40K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 2,135 | 1,740 | $38K |
| J0573 | Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine | 3,736 | 279 | $25K |
| 82075 | 6,132 | 4,171 | $23K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 551 | 336 | $22K |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 3,387 | 910 | $14K |
| 86580 | 2,228 | 1,760 | $12K | |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 901 | 66 | $7K |
| 99408 | 842 | 736 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 446 | 299 | $4K |
| 81025 | 566 | 350 | $3K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 74 | 44 | $3K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 20 | 12 | $0.00 |